{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:08:21Z","timestamp":1767139701723,"version":"build-2238731810"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T00:00:00Z","timestamp":1498694400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00292-017-0310-0","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T02:27:34Z","timestamp":1498703254000},"page":"331-344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Update der S3-Leitlinie f\u00fcr maligne Ovarialtumoren 2016","The 2016 update of the S3 guideline for malignant tumours of the ovary"],"prefix":"10.1007","volume":"38","author":[{"given":"A.","family":"Staebler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"310_CR1","volume-title":"WHO Classification of Tumors of Female Reproductive Organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RHE (2014) WHO Classification of Tumors of Female Reproductive Organs. IARC, Lyon"},{"key":"310_CR2","unstructured":"S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren Kurzversion 2.0 \u2013 Oktober 2016. \n                        http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/032-035-OLk_Ovarialkarzinom_2016-10.pdf\n                        \n                    . Zugegriffen: 30.05.2017"},{"key":"310_CR3","unstructured":"S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren Version 2.0 \u2013 Oktober 2016 AWMF-Registernummer: 032\/035OL. \n                        http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/032-035-OLl_Ovarialkarzinom_2016-10.pdf\n                        \n                    . Zugegriffen: 30.05.2017"},{"key":"310_CR4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1158\/1078-0432.CCR-13-1877","volume":"20","author":"JR Webb","year":"2014","unstructured":"Webb JR, Milne K, Watson P, Deleeuw RJ, Nelson BH (2014) Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin Cancer Res 20:434\u2013444","journal-title":"Clin. Cancer Res."},{"key":"310_CR5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/IGC.0b013e3181dbd1a5","volume":"20","author":"AH Trainer","year":"2010","unstructured":"Trainer AH, Meiser B, Watts K, Mitchell G, Tucker K, Friedlander M (2010) Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancer. Int J Gynecol Cancer 20:704\u2013716","journal-title":"Int. J. Gynecol. Cancer"},{"key":"310_CR6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cncr.24152","volume":"115","author":"C Tian","year":"2009","unstructured":"Tian C, Markman M, Zaino R et al (2009) CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a\u00a0Gynecologic Oncology Group study. Cancer 115:1395\u20131403","journal-title":"Cancer"},{"key":"310_CR7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.critrevonc.2009.01.007","volume":"72","author":"R Sabatier","year":"2009","unstructured":"Sabatier R, Finetti P, Cervera N, Birnbaum D, Bertucci F (2009) Gene expression profiling and prediction of clinical outcome in ovarian cancer. Crit Rev Oncol Hematol 72:98\u2013109","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"310_CR8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/OGX.0b013e3181abc114","volume":"64","author":"VN Harry","year":"2009","unstructured":"Harry VN, Gilbert FJ, Parkin DE (2009) Predicting the response of advanced cervical and ovarian tumors to therapy. Obstet Gynecol Surv 64:548\u2013560","journal-title":"Obstet Gynecol Surv"},{"key":"310_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/GCO.0b013e32832210ff","volume":"21","author":"IA Cree","year":"2009","unstructured":"Cree IA (2009) Chemosensitivity and chemoresistance testing in ovarian cancer. Curr Opin Obstet Gynecol 21:39\u201343","journal-title":"Curr Opin Obstet Gynecol"},{"key":"310_CR10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/156800909788486722","volume":"9","author":"F Bellati","year":"2009","unstructured":"Bellati F, Visconti V, Napoletano C et\u00a0al (2009) Immunology of gynecologic neoplasms: analysis of the prognostic significance of the immune status. Curr Cancer Drug Targets 9:541\u2013565","journal-title":"Curr Cancer Drug Targets"},{"key":"310_CR11","volume-title":"S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Kurzversion 2.0, 2016, AWMF-Registrierungsnummer: 032-035OL","author":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF)","year":"2016","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2016) S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Kurzversion 2.0, 2016, AWMF-Registrierungsnummer: 032-035OL. \n                        http:\/\/leitlinienprogramm-onkologie.de\/Ovarialkarzinom.61.0.html\n                        \n                    . Zugegriffen: 23. Mai 2017"},{"key":"310_CR12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","volume":"186","author":"RJ Kurman","year":"2016","unstructured":"Kurman RJ, Shih Ie M (2016) The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol 186:733\u2013747","journal-title":"Am. J. Pathol."},{"key":"310_CR13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e31803199b0","volume":"31","author":"A Malpica","year":"2007","unstructured":"Malpica A, Deavers MT, Tornos C et al (2007) Interobserver and intraobserver variability of a\u00a0two-tier system for grading ovarian serous carcinoma. Am J Surg Pathol 31:1168\u20131174","journal-title":"Am J Surg Pathol"},{"key":"310_CR14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","volume":"62","author":"R Vang","year":"2013","unstructured":"Vang R, Shih Ie M, Kurman RJ (2013) Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology 62:44\u201358","journal-title":"Histopathology"},{"key":"310_CR15","first-page":"625","volume":"3","author":"K Mehra","year":"2011","unstructured":"Mehra K, Mehrad M, Ning G et\u00a0al (2011) STICS, SCOUTs and p53 signatures; a\u00a0new language for pelvic serous carcinogenesis. Front Biosci 3:625\u2013634","journal-title":"Front Biosci"},{"key":"310_CR16","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","volume":"35","author":"K Visvanathan","year":"2011","unstructured":"Visvanathan K, Vang R, Shaw P et\u00a0al (2011) Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a\u00a0reproducibility study. Am J Surg Pathol 35:1766\u20131775","journal-title":"Am J Surg Pathol"},{"key":"310_CR17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/PAS.0000000000000405","volume":"39","author":"J Taylor","year":"2015","unstructured":"Taylor J, McCluggage WG (2015) Ovarian seromucinous carcinoma: report of a\u00a0series of a\u00a0newly categorized and uncommon neoplasm. Am J Surg Pathol 39:983\u2013992","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"310_CR18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PGP.0000000000000274","volume":"35","author":"M Kobel","year":"2016","unstructured":"Kobel M, Rahimi K, Rambau PF et\u00a0al (2016) An Immunohistochemical algorithm for ovarian carcinoma typing. Int J Gynecol Pathol 35(5):430\u2013441","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"8","key":"310_CR19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2015.77","volume":"28","author":"WG McCluggage","year":"2015","unstructured":"McCluggage WG, Judge MJ, Clarke BA et\u00a0al (2015) Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol 28(8):1101\u20131122","journal-title":"Mod Pathol"}],"updated-by":[{"DOI":"10.1007\/s00292-017-0372-z","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000}}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-017-0310-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-017-0310-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-017-0310-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T06:06:00Z","timestamp":1499839560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-017-0310-0"}},"subtitle":["Rolle der Pathologie in Diagnostik, Therapie und Nachsorge epithelialer Tumoren","Role of pathology in diagnosis, therapy and clinical management of epithelial tumours"],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1007\/s00292-017-0310-0","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,29]]}}}